Rani Therapeutics Targets $100 Million IPO
MaRussya/iStock via Getty Images
Quick Take
Rani Therapeutics Holdings (RANI) has filed to raise $100 million in an IPO of its Class A common stock, according to an S-1/A registration statement.
The company is a clinical stage biopharma developing reformulations…
